LESLIE BROWN: Open Payments
NPI 1831575562 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 46 payments from 21 companies in 2025. Trend: 2023 $686 · 2024 $1,234 · 2025 $1,283
Food & beverage: $1,273Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $355 |
| Genentech, Inc. | 1 | $130 |
| Lilly USA, LLC | 1 | $114 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $107 |
| ACADIA Pharmaceuticals Inc | 3 | $86 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Genentech USA, Inc. | 2 | $60 |
| Alexion Pharmaceuticals, Inc. | 2 | $50 |
| UCB, Inc. | 1 | $41 |
| PFIZER INC. | 1 | $31 |
Products named: QULIPTA, Ocrevus, REXULTI, KISUNLA, KESIMPTA, NUPLAZID, Ocrevus Zunovo, UBRELVY.
Industry payments across NV — which companies pay providers there.
